GL1X · GenesisL1 explorer

MolNFT v1 · #148327 · protein

IRAK4 in complex with inhibitor

6F3G · Interleukin-1 receptor-associated kinase 4: “IRAK4 in complex with inhibitor”. X-ray diffraction, 2 ligands (CJN, SO4), 5 pockets (best druggability 0.72). MolNFT v1 #148327 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
6F3G
Type
protein
Length
556 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Interleukin-1 receptor-associated kinase 4
EC
2.7.11.1
UniProt
Q9NWZ3
Ligands
CJN, SO4
Pockets
5 · best druggability 0.72

Structure

x-ray diffraction · 2 distinct chains · 44% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInterleukin-1 receptor-associated kinase 4 (EC 2.7.11.1)protein27743% helix, 17% strandQ9NWZ3
BInterleukin-1 receptor-associated kinase 4 (EC 2.7.11.1)protein27944% helix, 16% strandQ9NWZ3

Ligands and binding sites

  • CJN · ~{N}4,~{N}4-dimethyl-~{N}1-(5-propan-2-ylpyrrolo[3,2-d]pyrimidin-4-yl)cyclohexane-1,4-diamine · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17790.720.7750empty
24760.700.8050CJN
34200.640.7839CJN
4750.310.7412empty
5560.260.7314empty

Interfaces

1 interface between chains.

  • A–B · 595 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 modified (phosphorylation).

Compared structures

  • 6F3G · IRAK4 IN COMPLEX WITH inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.